In liver biopsies obtained from NAFLD patients, the activation of the IRE1α signaling pathway was accompanied by BI-1 downregulation, suggesting that the IRE1α signaling pathway contributed to NAFLD. This evidence concerns the gene TMBIM6 and metabolic dysfunction-associated steatotic liver disease.